Document Detail

Open-angle glaucoma.
MedLine Citation:
PMID:  12751655     Owner:  NLM     Status:  MEDLINE    
Glaucoma is the second most common cause of legal blindness in the United States. Open-angle glaucoma is an asymptomatic, progressive optic neuropathy characterized by enlarging optic disc cupping and visual field loss. Patients at increased risk for open-angle glaucoma include blacks older than 40 years, whites older than 65 years, and persons with a family history of glaucoma or a personal history of diabetes or severe myopia. Elevated intraocular pressure is a strong, modifiable risk factor for open-angle glaucoma, but it is not diagnostic. Some patients with glaucoma have normal intraocular pressure (i.e., normal-pressure glaucoma), and many patients with elevated intraocular pressure do not have glaucoma (i.e., glaucoma suspects). Routine measurement of intraocular pressure by primary care physicians to screen patients for glaucoma is not recommended. Open-angle glaucoma usually is discovered during an adult eye evaluation performed for other indications. Final diagnosis and treatment occur in collaboration with ophthalmologists and optometrists. Formal visual field testing (perimetry) is a mainstay of glaucoma diagnosis and management. Eye drops, commonly nonspecific beta-blocker or prostaglandin analog drops, generally are the first-line treatment to reduce intraocular pressure. Laser treatment and surgery usually are reserved for patients in whom medical treatment has failed. Without treatment, open-angle glaucoma can end in irreversible vision loss.
James S Distelhorst; Grady M Hughes
Related Documents :
17499235 - Hypotensive effect of profilin on rabbit intraocular pressure.
12169965 - A prospective randomized trial of viscocanalostomy versus trabeculectomy in open-angle ...
11931075 - Outflow facilities through descemet's membrane in rabbits.
6541215 - Effect of topically applied forskolin on aqueous humor dynamics in cynomolgus monkey.
17278975 - Increased arterial stiffness in remote indigenous australians with high risk of cardiov...
12405605 - A dual-pressure boundary condition for use in simulations of bifurcating conduits.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American family physician     Volume:  67     ISSN:  0002-838X     ISO Abbreviation:  Am Fam Physician     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-05-19     Completed Date:  2003-06-17     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  1272646     Medline TA:  Am Fam Physician     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1937-44     Citation Subset:  AIM; IM    
Milliman Care Guidelines, Division of Milliman, Seattle, Washington 98104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic alpha-Agonists / therapeutic use
Adrenergic beta-Antagonists / therapeutic use
Blindness / etiology
Glaucoma, Open-Angle / diagnosis*,  drug therapy*,  surgery
Mass Screening
Ophthalmic Solutions / therapeutic use
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Adrenergic beta-Antagonists; 0/Ophthalmic Solutions

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recognition and management of bioterrorism infections.
Next Document:  Diagnosis and management of positional head deformity.